The multidisciplinary team should meet to discuss patients with unusual pathology, any patient where treatment may be unclear, and all patients with stage III and IV disease, within four weeks of the initial diagnosis. The level of discussion may vary, depending on the patient’s clinical and supportive care factors. Some patients with non-complex melanoma may not be discussed by a multidisciplinary team; instead the team may have treatment plan protocols that will be applied if the patient’s case (melanoma) meets the criteria. If patients are not discussed at an MDM, they should at least be named on the agenda for noting. The proposed treatment must be recorded in the patient’s medical record and should be recorded in an MDM database where one exists.

Teams may agree on standard treatment protocols for non-complex care, facilitating patient review (by exception) and associated data capture.

Results of all relevant tests and access to images should be available for the MDM. Information about the patient’s concerns, preferences and social and cultural circumstances should also be available.